RenovoRx, Inc.
RNXT- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001574094
No open-market purchases or sales by RenovoRx, Inc. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $9.00M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding RenovoRx, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 13 | 18 | +5 |
| Shares | 1.89M | 1.01M | −876.7K (−46.4%) |
| Value | $2.00M | $1.31M | −$695.2K (−34.7%) |
New holders (6)
Institutions that held RenovoRx, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 64,900 | $83.7K | 0.00% |
| Citadel Advisors LLC | 37,757 | $48.7K | 0.00% |
| XTX Topco Ltd | 12,640 | $16.3K | 0.00% |
| Two Sigma Securities, LLC | 11,704 | $15.1K | 0.00% |
| Citigroup Inc | 384 | $495 | 0.00% |
| JPMorgan Chase & Co | 40 | $52 | 0.00% |
Sold out (1)
Institutions that held RenovoRx, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Bank of Montreal | 975,000 | $1.03M |